Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

NCT00469781 is registered in ClinicalTrials.gov with Center For Excellence In Eye Care as lead sponsor.

NCT NCT00469781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
Lead sponsor
Center For Excellence In Eye Care
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2007
Completion date
September 30, 2008
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystoid macular edema,, retinal thickening